HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.

Abstract
A novel series of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline were synthesized and tested for their antiproliferative activities against five human cancer cell lines including A549 (lung cancer), MCF-7 (breast adenocarcinoma), HeLa (cervical carcinoma), HT29 and HCT-116 (colorectal cancer). Most of the synthesized compounds showed broad spectrum antiproliferative activity (IC50 1.47-11.83 μM), of which 8f, 8m and 8q were the most active members with IC50 values in the range of 1.58-2.27, 1.84-3.27 and 1.47-4.68 μM against five cancer cell lines examined, respectively. Further investigations revealed that compounds 8f, 8m and 8q exhibited weak inhibition against dihydrofolate reductase and no activity against thymidylate synthase, while induced DNA damage and activated the G2/M checkpoint in HCT-116 cells.
AuthorsSheng-Li Cao, Ying Han, Chong-Zhen Yuan, Yao Wang, Zhi-Kai Xiahou, Ji Liao, Rui-Ting Gao, Bei-Bei Mao, Bao-Li Zhao, Zhong-Feng Li, Xingzhi Xu
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 64 Pg. 401-9 (Jun 2013) ISSN: 1768-3254 [Electronic] France
PMID23665106 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Piperazines
  • Quinazolines
  • Thiocarbamates
  • 2,4-diaminoquinazoline
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Dose-Response Relationship, Drug
  • HCT116 Cells
  • HT29 Cells
  • HeLa Cells
  • Humans
  • MCF-7 Cells
  • Molecular Structure
  • Piperazines (chemistry)
  • Quinazolines (chemical synthesis, chemistry, pharmacology)
  • Structure-Activity Relationship
  • Thiocarbamates (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: